N01269 604

Kharkiv

0 studies enrolling now · 1 studies all time

What they study most

Childhood Absence Epilepsy, Juvenile Absence Epilepsy

Studies at this site

• A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy — Completed